nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—EGFR—hypertension	0.0971	0.366	CbGaD
Erlotinib—CYP3A5—hypertension	0.082	0.309	CbGaD
Erlotinib—CYP1A1—hypertension	0.0556	0.209	CbGaD
Erlotinib—ALB—hypertension	0.0309	0.117	CbGaD
Erlotinib—ORM1—Penbutolol—hypertension	0.0138	0.0329	CbGbCtD
Erlotinib—ORM1—Doxazosin—hypertension	0.0133	0.0316	CbGbCtD
Erlotinib—SLCO2B1—Atorvastatin—hypertension	0.011	0.0261	CbGbCtD
Erlotinib—ORM1—Prazosin—hypertension	0.0109	0.026	CbGbCtD
Erlotinib—ORM1—Propranolol—hypertension	0.0087	0.0206	CbGbCtD
Erlotinib—UGT1A1—Atorvastatin—hypertension	0.00821	0.0195	CbGbCtD
Erlotinib—ALB—Ethacrynic acid—hypertension	0.00769	0.0182	CbGbCtD
Erlotinib—UGT1A1—Losartan—hypertension	0.0075	0.0178	CbGbCtD
Erlotinib—ABCG2—Telmisartan—hypertension	0.00739	0.0175	CbGbCtD
Erlotinib—ABCG2—Prazosin—hypertension	0.00668	0.0159	CbGbCtD
Erlotinib—STK10—renal vein—hypertension	0.00624	0.116	CbGeAlD
Erlotinib—CYP1A1—Prazosin—hypertension	0.00617	0.0146	CbGbCtD
Erlotinib—CYP2C8—Torasemide—hypertension	0.00594	0.0141	CbGbCtD
Erlotinib—CYP1A1—Amlodipine—hypertension	0.0058	0.0138	CbGbCtD
Erlotinib—CYP2C8—Candesartan—hypertension	0.00552	0.0131	CbGbCtD
Erlotinib—CYP1A1—Nifedipine—hypertension	0.00541	0.0128	CbGbCtD
Erlotinib—CYP1A1—Carvedilol—hypertension	0.00532	0.0126	CbGbCtD
Erlotinib—CYP3A5—Reserpine—hypertension	0.00512	0.0121	CbGbCtD
Erlotinib—ALB—Valsartan—hypertension	0.00495	0.0118	CbGbCtD
Erlotinib—CYP1A1—Propranolol—hypertension	0.0049	0.0116	CbGbCtD
Erlotinib—CYP1A1—Clonidine—hypertension	0.00467	0.0111	CbGbCtD
Erlotinib—CYP1A2—Guanabenz—hypertension	0.0046	0.0109	CbGbCtD
Erlotinib—CYP1A2—Triamterene—hypertension	0.0046	0.0109	CbGbCtD
Erlotinib—CYP3A5—Nisoldipine—hypertension	0.00451	0.0107	CbGbCtD
Erlotinib—ABCB1—Nadolol—hypertension	0.0044	0.0104	CbGbCtD
Erlotinib—CYP3A5—Diltiazem—hypertension	0.00435	0.0103	CbGbCtD
Erlotinib—CYP3A5—Eplerenone—hypertension	0.00435	0.0103	CbGbCtD
Erlotinib—STK10—renal artery—hypertension	0.00419	0.0776	CbGeAlD
Erlotinib—CYP2C8—Diltiazem—hypertension	0.00419	0.00993	CbGbCtD
Erlotinib—CYP2D6—Labetalol—hypertension	0.00414	0.00983	CbGbCtD
Erlotinib—CYP2D6—Nebivolol—hypertension	0.00414	0.00983	CbGbCtD
Erlotinib—ABCB1—Acebutolol—hypertension	0.00402	0.00954	CbGbCtD
Erlotinib—CYP1A2—Betaxolol—hypertension	0.00381	0.00904	CbGbCtD
Erlotinib—CYP2D6—Acebutolol—hypertension	0.00379	0.00899	CbGbCtD
Erlotinib—ABCB1—Candesartan—hypertension	0.00374	0.00887	CbGbCtD
Erlotinib—ABCB1—Metoprolol—hypertension	0.00374	0.00887	CbGbCtD
Erlotinib—ABCG2—Verapamil—hypertension	0.00364	0.00864	CbGbCtD
Erlotinib—ALB—Captopril—hypertension	0.00361	0.00857	CbGbCtD
Erlotinib—CYP2D6—Pindolol—hypertension	0.00352	0.00836	CbGbCtD
Erlotinib—CYP2D6—Metoprolol—hypertension	0.00352	0.00836	CbGbCtD
Erlotinib—ABCB1—Terazosin—hypertension	0.00352	0.00834	CbGbCtD
Erlotinib—CYP3A5—Amlodipine—hypertension	0.00348	0.00826	CbGbCtD
Erlotinib—CYP3A4—Guanethidine—hypertension	0.00348	0.00825	CbGbCtD
Erlotinib—CYP2C8—Irbesartan—hypertension	0.00341	0.0081	CbGbCtD
Erlotinib—CYP3A5—Felodipine—hypertension	0.00336	0.00796	CbGbCtD
Erlotinib—CYP1A2—Nisoldipine—hypertension	0.00335	0.00796	CbGbCtD
Erlotinib—CYP2C8—Amlodipine—hypertension	0.00335	0.00794	CbGbCtD
Erlotinib—ABCB1—Reserpine—hypertension	0.00333	0.00791	CbGbCtD
Erlotinib—CYP2C8—Spironolactone—hypertension	0.00328	0.00779	CbGbCtD
Erlotinib—CYP3A5—Nifedipine—hypertension	0.00325	0.0077	CbGbCtD
Erlotinib—CYP2C8—Felodipine—hypertension	0.00323	0.00766	CbGbCtD
Erlotinib—CYP3A5—Nicardipine—hypertension	0.0032	0.00758	CbGbCtD
Erlotinib—CYP2D6—Betaxolol—hypertension	0.00314	0.00745	CbGbCtD
Erlotinib—CYP2C8—Nifedipine—hypertension	0.00312	0.0074	CbGbCtD
Erlotinib—CYP2C8—Nicardipine—hypertension	0.00307	0.00729	CbGbCtD
Erlotinib—ABCB1—Perindopril—hypertension	0.00305	0.00723	CbGbCtD
Erlotinib—CYP3A5—Propranolol—hypertension	0.00294	0.00698	CbGbCtD
Erlotinib—ABCB1—Doxazosin—hypertension	0.00293	0.00696	CbGbCtD
Erlotinib—ABCB1—Nisoldipine—hypertension	0.00293	0.00696	CbGbCtD
Erlotinib—ALB—Furosemide—hypertension	0.0029	0.00689	CbGbCtD
Erlotinib—ALB—Losartan—hypertension	0.00285	0.00675	CbGbCtD
Erlotinib—ABCB1—Diltiazem—hypertension	0.00283	0.00672	CbGbCtD
Erlotinib—CYP3A5—Clonidine—hypertension	0.00281	0.00666	CbGbCtD
Erlotinib—CYP2D6—Doxazosin—hypertension	0.00276	0.00656	CbGbCtD
Erlotinib—CYP2D6—Diltiazem—hypertension	0.00267	0.00633	CbGbCtD
Erlotinib—ABCB1—Telmisartan—hypertension	0.00266	0.00632	CbGbCtD
Erlotinib—CYP1A2—Irbesartan—hypertension	0.00264	0.00627	CbGbCtD
Erlotinib—CYP3A4—Hydralazine—hypertension	0.00263	0.00625	CbGbCtD
Erlotinib—CYP1A2—Amlodipine—hypertension	0.00259	0.00615	CbGbCtD
Erlotinib—ABCB1—Enalapril—hypertension	0.00253	0.00599	CbGbCtD
Erlotinib—ABCB1—Lisinopril—hypertension	0.00253	0.00599	CbGbCtD
Erlotinib—ABCB1—Bepridil—hypertension	0.00253	0.00599	CbGbCtD
Erlotinib—CYP3A5—Atorvastatin—hypertension	0.0025	0.00593	CbGbCtD
Erlotinib—CYP1A2—Nifedipine—hypertension	0.00242	0.00573	CbGbCtD
Erlotinib—ABCB1—Prazosin—hypertension	0.00241	0.00572	CbGbCtD
Erlotinib—CYP2C8—Atorvastatin—hypertension	0.0024	0.0057	CbGbCtD
Erlotinib—CYP2D6—Bepridil—hypertension	0.00238	0.00565	CbGbCtD
Erlotinib—CYP1A2—Carvedilol—hypertension	0.00238	0.00564	CbGbCtD
Erlotinib—CYP3A5—Losartan—hypertension	0.00229	0.00543	CbGbCtD
Erlotinib—ABCB1—Amlodipine—hypertension	0.00227	0.00537	CbGbCtD
Erlotinib—CYP3A4—Guanfacine—hypertension	0.00224	0.00531	CbGbCtD
Erlotinib—ABCB1—Spironolactone—hypertension	0.00222	0.00528	CbGbCtD
Erlotinib—CYP2C8—Losartan—hypertension	0.0022	0.00522	CbGbCtD
Erlotinib—CYP1A2—Propranolol—hypertension	0.00219	0.00519	CbGbCtD
Erlotinib—ABCB1—Felodipine—hypertension	0.00218	0.00518	CbGbCtD
Erlotinib—CYP2D6—Irbesartan—hypertension	0.00218	0.00516	CbGbCtD
Erlotinib—ABCB1—Timolol—hypertension	0.00215	0.00509	CbGbCtD
Erlotinib—CYP2D6—Amlodipine—hypertension	0.00213	0.00506	CbGbCtD
Erlotinib—ABCB1—Nifedipine—hypertension	0.00211	0.00501	CbGbCtD
Erlotinib—CYP1A2—Clonidine—hypertension	0.00209	0.00495	CbGbCtD
Erlotinib—ABCB1—Nicardipine—hypertension	0.00208	0.00493	CbGbCtD
Erlotinib—ABCB1—Carvedilol—hypertension	0.00208	0.00493	CbGbCtD
Erlotinib—CYP2D6—Felodipine—hypertension	0.00206	0.00488	CbGbCtD
Erlotinib—CYP2D6—Timolol—hypertension	0.00202	0.0048	CbGbCtD
Erlotinib—CYP3A5—Verapamil—hypertension	0.00202	0.00479	CbGbCtD
Erlotinib—CYP3A4—Isradipine—hypertension	0.002	0.00474	CbGbCtD
Erlotinib—CYP2D6—Nifedipine—hypertension	0.00199	0.00472	CbGbCtD
Erlotinib—CYP2D6—Nicardipine—hypertension	0.00196	0.00465	CbGbCtD
Erlotinib—CYP2D6—Carvedilol—hypertension	0.00196	0.00465	CbGbCtD
Erlotinib—CYP2C8—Verapamil—hypertension	0.00194	0.0046	CbGbCtD
Erlotinib—ABCB1—Propranolol—hypertension	0.00191	0.00454	CbGbCtD
Erlotinib—ABCB1—Captopril—hypertension	0.00189	0.00449	CbGbCtD
Erlotinib—ABCB1—Clonidine—hypertension	0.00183	0.00433	CbGbCtD
Erlotinib—CYP2D6—Propranolol—hypertension	0.0018	0.00428	CbGbCtD
Erlotinib—CYP2D6—Captopril—hypertension	0.00178	0.00423	CbGbCtD
Erlotinib—CYP3A4—Indapamide—hypertension	0.00176	0.00417	CbGbCtD
Erlotinib—CYP3A4—Nisoldipine—hypertension	0.00176	0.00417	CbGbCtD
Erlotinib—CYP2D6—Clonidine—hypertension	0.00172	0.00408	CbGbCtD
Erlotinib—CYP1A2—Losartan—hypertension	0.0017	0.00404	CbGbCtD
Erlotinib—CYP3A4—Eplerenone—hypertension	0.0017	0.00403	CbGbCtD
Erlotinib—CYP3A4—Diltiazem—hypertension	0.0017	0.00403	CbGbCtD
Erlotinib—ABCB1—Atorvastatin—hypertension	0.00163	0.00386	CbGbCtD
Erlotinib—CYP2D6—Atorvastatin—hypertension	0.00153	0.00364	CbGbCtD
Erlotinib—CYP3A4—Enalapril—hypertension	0.00151	0.00359	CbGbCtD
Erlotinib—CYP1A2—Verapamil—hypertension	0.0015	0.00356	CbGbCtD
Erlotinib—ABCB1—Losartan—hypertension	0.00149	0.00353	CbGbCtD
Erlotinib—CYP3A4—Irbesartan—hypertension	0.00138	0.00328	CbGbCtD
Erlotinib—CYP3A4—Amlodipine—hypertension	0.00136	0.00322	CbGbCtD
Erlotinib—ABCB1—Verapamil—hypertension	0.00131	0.00312	CbGbCtD
Erlotinib—CYP3A4—Felodipine—hypertension	0.00131	0.0031	CbGbCtD
Erlotinib—CYP3A4—Nifedipine—hypertension	0.00127	0.003	CbGbCtD
Erlotinib—CYP3A4—Carvedilol—hypertension	0.00125	0.00296	CbGbCtD
Erlotinib—CYP3A4—Nicardipine—hypertension	0.00125	0.00296	CbGbCtD
Erlotinib—CYP2D6—Verapamil—hypertension	0.00124	0.00294	CbGbCtD
Erlotinib—CYP3A4—Propranolol—hypertension	0.00115	0.00272	CbGbCtD
Erlotinib—UGT1A1—urine—hypertension	0.00111	0.0206	CbGeAlD
Erlotinib—CYP3A4—Clonidine—hypertension	0.00109	0.0026	CbGbCtD
Erlotinib—CYP3A4—Atorvastatin—hypertension	0.000975	0.00231	CbGbCtD
Erlotinib—CYP3A4—Losartan—hypertension	0.000892	0.00212	CbGbCtD
Erlotinib—CYP3A4—Verapamil—hypertension	0.000787	0.00187	CbGbCtD
Erlotinib—AURKC—heart—hypertension	0.000617	0.0114	CbGeAlD
Erlotinib—ULK3—cardiac ventricle—hypertension	0.000592	0.011	CbGeAlD
Erlotinib—PIP4K2C—myocardium—hypertension	0.000583	0.0108	CbGeAlD
Erlotinib—JAK3—heart—hypertension	0.000571	0.0106	CbGeAlD
Erlotinib—MKNK1—cardiac ventricle—hypertension	0.000557	0.0103	CbGeAlD
Erlotinib—ULK3—myocardium—hypertension	0.000557	0.0103	CbGeAlD
Erlotinib—SLK—cardiac ventricle—hypertension	0.000528	0.00977	CbGeAlD
Erlotinib—TNK1—heart—hypertension	0.000524	0.00971	CbGeAlD
Erlotinib—MKNK1—myocardium—hypertension	0.000524	0.00971	CbGeAlD
Erlotinib—TNK1—decidua—hypertension	0.00051	0.00945	CbGeAlD
Erlotinib—SLK—myocardium—hypertension	0.000496	0.00919	CbGeAlD
Erlotinib—CYP1A2—urine—hypertension	0.000492	0.0091	CbGeAlD
Erlotinib—Vandetanib—PDGFRB—hypertension	0.00048	0.165	CrCbGaD
Erlotinib—HIPK4—endocrine gland—hypertension	0.000468	0.00866	CbGeAlD
Erlotinib—NR1I2—endocrine gland—hypertension	0.000462	0.00857	CbGeAlD
Erlotinib—AURKC—adrenal gland—hypertension	0.00046	0.00853	CbGeAlD
Erlotinib—FLT3—heart—hypertension	0.000451	0.00835	CbGeAlD
Erlotinib—MKNK1—Pindolol—Nadolol—hypertension	0.000434	0.219	CbGdCrCtD
Erlotinib—ABL2—heart—hypertension	0.00043	0.00797	CbGeAlD
Erlotinib—PIP4K2C—nephron tubule—hypertension	0.000428	0.00792	CbGeAlD
Erlotinib—JAK3—adrenal gland—hypertension	0.000426	0.0079	CbGeAlD
Erlotinib—FLT3—cardiovascular system—hypertension	0.000425	0.00787	CbGeAlD
Erlotinib—PIP4K2C—adrenal cortex—hypertension	0.000421	0.00779	CbGeAlD
Erlotinib—EGFR—heart—hypertension	0.00042	0.00778	CbGeAlD
Erlotinib—PIP4K2C—heart—hypertension	0.000407	0.00754	CbGeAlD
Erlotinib—ULK3—adrenal cortex—hypertension	0.000402	0.00744	CbGeAlD
Erlotinib—AURKC—endocrine gland—hypertension	0.000399	0.00739	CbGeAlD
Erlotinib—PIP4K2C—decidua—hypertension	0.000396	0.00733	CbGeAlD
Erlotinib—TNK1—adrenal gland—hypertension	0.000391	0.00725	CbGeAlD
Erlotinib—ULK3—heart—hypertension	0.000389	0.0072	CbGeAlD
Erlotinib—Vandetanib—SRC—hypertension	0.000387	0.133	CrCbGaD
Erlotinib—MAP2K5—myocardium—hypertension	0.000385	0.00714	CbGeAlD
Erlotinib—MKNK1—Pindolol—Acebutolol—hypertension	0.000382	0.193	CbGdCrCtD
Erlotinib—MKNK1—adrenal cortex—hypertension	0.000378	0.007	CbGeAlD
Erlotinib—ULK3—decidua—hypertension	0.000378	0.007	CbGeAlD
Erlotinib—EPHA6—endocrine gland—hypertension	0.00037	0.00685	CbGeAlD
Erlotinib—JAK3—endocrine gland—hypertension	0.00037	0.00685	CbGeAlD
Erlotinib—PIP4K2C—cortex of kidney—hypertension	0.000366	0.00678	CbGeAlD
Erlotinib—MKNK1—heart—hypertension	0.000366	0.00677	CbGeAlD
Erlotinib—SLK—nephron tubule—hypertension	0.000364	0.00674	CbGeAlD
Erlotinib—Vandetanib—KDR—hypertension	0.000364	0.125	CrCbGaD
Erlotinib—Vandetanib—ABCC1—hypertension	0.00036	0.124	CrCbGaD
Erlotinib—AURKC—central nervous system—hypertension	0.00036	0.00666	CbGeAlD
Erlotinib—SLK—adrenal cortex—hypertension	0.000358	0.00663	CbGeAlD
Erlotinib—CYP3A4—urine—hypertension	0.000356	0.00659	CbGeAlD
Erlotinib—MKNK1—decidua—hypertension	0.000356	0.00659	CbGeAlD
Erlotinib—CYP2D6—urine—hypertension	0.00035	0.00648	CbGeAlD
Erlotinib—ULK3—cortex of kidney—hypertension	0.000349	0.00647	CbGeAlD
Erlotinib—PIP4K2C—cardiac atrium—hypertension	0.000348	0.00645	CbGeAlD
Erlotinib—MKNK1—Pindolol—Metoprolol—hypertension	0.000347	0.175	CbGdCrCtD
Erlotinib—SLK—heart—hypertension	0.000346	0.00642	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—hypertension	0.000345	0.00639	CbGeAlD
Erlotinib—TNK1—endocrine gland—hypertension	0.000339	0.00629	CbGeAlD
Erlotinib—SLK—decidua—hypertension	0.000337	0.00624	CbGeAlD
Erlotinib—FLT3—adrenal gland—hypertension	0.000336	0.00623	CbGeAlD
Erlotinib—JAK3—central nervous system—hypertension	0.000333	0.00617	CbGeAlD
Erlotinib—EPHA6—central nervous system—hypertension	0.000333	0.00617	CbGeAlD
Erlotinib—ULK3—cardiac atrium—hypertension	0.000332	0.00616	CbGeAlD
Erlotinib—MKNK1—Pindolol—Esmolol—hypertension	0.000329	0.166	CbGdCrCtD
Erlotinib—MKNK1—cortex of kidney—hypertension	0.000329	0.00609	CbGeAlD
Erlotinib—PIP4K2C—medulla oblongata—hypertension	0.000328	0.00608	CbGeAlD
Erlotinib—ABL2—adrenal gland—hypertension	0.000321	0.00595	CbGeAlD
Erlotinib—ABL1—cardiac ventricle—hypertension	0.000316	0.00585	CbGeAlD
Erlotinib—EGFR—adrenal gland—hypertension	0.000313	0.0058	CbGeAlD
Erlotinib—ULK3—medulla oblongata—hypertension	0.000313	0.0058	CbGeAlD
Erlotinib—MKNK1—cardiac atrium—hypertension	0.000313	0.00579	CbGeAlD
Erlotinib—SLK—cortex of kidney—hypertension	0.000311	0.00577	CbGeAlD
Erlotinib—MAP2K5—brainstem—hypertension	0.000311	0.00576	CbGeAlD
Erlotinib—Vandetanib—VEGFA—hypertension	0.000308	0.106	CrCbGaD
Erlotinib—PIP4K2C—adrenal gland—hypertension	0.000304	0.00563	CbGeAlD
Erlotinib—MAP3K19—central nervous system—hypertension	0.000303	0.00561	CbGeAlD
Erlotinib—STK10—heart—hypertension	0.000301	0.00558	CbGeAlD
Erlotinib—ABL1—myocardium—hypertension	0.000297	0.00551	CbGeAlD
Erlotinib—SLK—cardiac atrium—hypertension	0.000296	0.00549	CbGeAlD
Erlotinib—MKNK1—medulla oblongata—hypertension	0.000295	0.00546	CbGeAlD
Erlotinib—STK10—decidua—hypertension	0.000293	0.00543	CbGeAlD
Erlotinib—FLT3—endocrine gland—hypertension	0.000292	0.0054	CbGeAlD
Erlotinib—ULK3—adrenal gland—hypertension	0.00029	0.00537	CbGeAlD
Erlotinib—MKNK1—Pindolol—Betaxolol—hypertension	0.00029	0.146	CbGdCrCtD
Erlotinib—STK10—cardiovascular system—hypertension	0.000284	0.00526	CbGeAlD
Erlotinib—SLK—medulla oblongata—hypertension	0.000279	0.00517	CbGeAlD
Erlotinib—MAP2K5—adrenal cortex—hypertension	0.000278	0.00515	CbGeAlD
Erlotinib—STK10—kidney—hypertension	0.000278	0.00515	CbGeAlD
Erlotinib—MKNK1—adrenal gland—hypertension	0.000273	0.00506	CbGeAlD
Erlotinib—MAP2K5—heart—hypertension	0.000269	0.00498	CbGeAlD
Erlotinib—PIP4K2C—endocrine gland—hypertension	0.000263	0.00488	CbGeAlD
Erlotinib—UGT1A1—kidney—hypertension	0.000263	0.00486	CbGeAlD
Erlotinib—MAP2K5—decidua—hypertension	0.000262	0.00485	CbGeAlD
Erlotinib—Vandetanib—EGFR—hypertension	0.00026	0.0892	CrCbGaD
Erlotinib—SLK—adrenal gland—hypertension	0.000259	0.00479	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—hypertension	0.000254	0.0047	CbGeAlD
Erlotinib—ULK3—endocrine gland—hypertension	0.000252	0.00466	CbGeAlD
Erlotinib—Gefitinib—EGFR—hypertension	0.000247	0.0847	CrCbGaD
Erlotinib—MAP2K5—cortex of kidney—hypertension	0.000242	0.00448	CbGeAlD
Erlotinib—ABL1—brainstem—hypertension	0.00024	0.00444	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—hypertension	0.000237	0.0044	CbGeAlD
Erlotinib—MKNK1—endocrine gland—hypertension	0.000237	0.00438	CbGeAlD
Erlotinib—MAP2K5—cardiac atrium—hypertension	0.00023	0.00426	CbGeAlD
Erlotinib—ULK3—central nervous system—hypertension	0.000227	0.0042	CbGeAlD
Erlotinib—STK10—adrenal gland—hypertension	0.000225	0.00416	CbGeAlD
Erlotinib—ABL1—nephron tubule—hypertension	0.000218	0.00404	CbGeAlD
Erlotinib—MAP2K5—medulla oblongata—hypertension	0.000217	0.00402	CbGeAlD
Erlotinib—ABL1—adrenal cortex—hypertension	0.000215	0.00397	CbGeAlD
Erlotinib—MKNK1—central nervous system—hypertension	0.000213	0.00395	CbGeAlD
Erlotinib—SLCO2B1—heart—hypertension	0.000209	0.00388	CbGeAlD
Erlotinib—Gefitinib—CYP3A5—hypertension	0.000209	0.0715	CrCbGaD
Erlotinib—ABL1—heart—hypertension	0.000208	0.00384	CbGeAlD
Erlotinib—ABL1—smooth muscle tissue—hypertension	0.000206	0.00381	CbGeAlD
Erlotinib—SLCO2B1—decidua—hypertension	0.000204	0.00377	CbGeAlD
Erlotinib—ABL1—decidua—hypertension	0.000202	0.00374	CbGeAlD
Erlotinib—MAP2K5—adrenal gland—hypertension	0.000201	0.00372	CbGeAlD
Erlotinib—MKNK1—Pindolol—Propranolol—hypertension	0.000196	0.0993	CbGdCrCtD
Erlotinib—ABL1—cardiovascular system—hypertension	0.000196	0.00363	CbGeAlD
Erlotinib—STK10—endocrine gland—hypertension	0.000195	0.00361	CbGeAlD
Erlotinib—SLCO2B1—kidney—hypertension	0.000193	0.00358	CbGeAlD
Erlotinib—ABL1—kidney—hypertension	0.000192	0.00355	CbGeAlD
Erlotinib—ALB—heart—hypertension	0.000191	0.00355	CbGeAlD
Erlotinib—CYP1A1—cardiac ventricle—hypertension	0.000189	0.0035	CbGeAlD
Erlotinib—ABL1—cortex of kidney—hypertension	0.000187	0.00346	CbGeAlD
Erlotinib—CYP1B1—nephron tubule—hypertension	0.000185	0.00342	CbGeAlD
Erlotinib—UGT1A1—endocrine gland—hypertension	0.000184	0.00341	CbGeAlD
Erlotinib—ABL1—cardiac atrium—hypertension	0.000177	0.00329	CbGeAlD
Erlotinib—CYP1B1—heart—hypertension	0.000176	0.00325	CbGeAlD
Erlotinib—STK10—central nervous system—hypertension	0.000176	0.00325	CbGeAlD
Erlotinib—CYP1B1—smooth muscle tissue—hypertension	0.000174	0.00323	CbGeAlD
Erlotinib—MAP2K5—endocrine gland—hypertension	0.000174	0.00322	CbGeAlD
Erlotinib—CYP1B1—decidua—hypertension	0.000171	0.00317	CbGeAlD
Erlotinib—SLCO2B1—medulla oblongata—hypertension	0.000169	0.00313	CbGeAlD
Erlotinib—ABL1—medulla oblongata—hypertension	0.000167	0.0031	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—hypertension	0.000166	0.00307	CbGeAlD
Erlotinib—CYP1B1—kidney—hypertension	0.000162	0.00301	CbGeAlD
Erlotinib—CYP1B1—cortex of kidney—hypertension	0.000158	0.00293	CbGeAlD
Erlotinib—MAP2K5—central nervous system—hypertension	0.000157	0.00291	CbGeAlD
Erlotinib—SLCO2B1—adrenal gland—hypertension	0.000156	0.00289	CbGeAlD
Erlotinib—ABL1—adrenal gland—hypertension	0.000155	0.00287	CbGeAlD
Erlotinib—ALB—adrenal gland—hypertension	0.000143	0.00265	CbGeAlD
Erlotinib—Gefitinib—CYP1A1—hypertension	0.000141	0.0485	CrCbGaD
Erlotinib—ORM1—endocrine gland—hypertension	0.000141	0.00262	CbGeAlD
Erlotinib—ABCG2—nephron tubule—hypertension	0.000137	0.00255	CbGeAlD
Erlotinib—ABCB1—blood vessel—hypertension	0.000136	0.00253	CbGeAlD
Erlotinib—SLCO2B1—endocrine gland—hypertension	0.000135	0.00251	CbGeAlD
Erlotinib—ABCG2—adrenal cortex—hypertension	0.000135	0.00251	CbGeAlD
Erlotinib—ABL1—endocrine gland—hypertension	0.000134	0.00249	CbGeAlD
Erlotinib—CYP1B1—adrenal gland—hypertension	0.000131	0.00243	CbGeAlD
Erlotinib—ABCG2—heart—hypertension	0.000131	0.00242	CbGeAlD
Erlotinib—CYP3A5—nephron tubule—hypertension	0.000128	0.00236	CbGeAlD
Erlotinib—ORM1—central nervous system—hypertension	0.000127	0.00236	CbGeAlD
Erlotinib—ABCG2—decidua—hypertension	0.000127	0.00236	CbGeAlD
Erlotinib—CYP2C8—kidney—hypertension	0.000124	0.0023	CbGeAlD
Erlotinib—CYP1A1—heart—hypertension	0.000124	0.0023	CbGeAlD
Erlotinib—SLCO2B1—central nervous system—hypertension	0.000122	0.00226	CbGeAlD
Erlotinib—ABL1—central nervous system—hypertension	0.000121	0.00224	CbGeAlD
Erlotinib—CYP1A1—kidney—hypertension	0.000115	0.00212	CbGeAlD
Erlotinib—CYP1B1—endocrine gland—hypertension	0.000114	0.00211	CbGeAlD
Erlotinib—CYP3A5—kidney—hypertension	0.000112	0.00208	CbGeAlD
Erlotinib—CYP3A5—cortex of kidney—hypertension	0.000109	0.00202	CbGeAlD
Erlotinib—CYP1A1—cardiac atrium—hypertension	0.000106	0.00197	CbGeAlD
Erlotinib—ABCG2—medulla oblongata—hypertension	0.000105	0.00195	CbGeAlD
Erlotinib—CYP2D6—brainstem—hypertension	0.000104	0.00192	CbGeAlD
Erlotinib—CYP1B1—central nervous system—hypertension	0.000102	0.0019	CbGeAlD
Erlotinib—ABCG2—adrenal gland—hypertension	9.77e-05	0.00181	CbGeAlD
Erlotinib—CYP2C8—endocrine gland—hypertension	8.71e-05	0.00161	CbGeAlD
Erlotinib—CYP3A4—kidney—hypertension	8.42e-05	0.00156	CbGeAlD
Erlotinib—Vandetanib—ALB—hypertension	8.29e-05	0.0284	CrCbGaD
Erlotinib—CYP2D6—kidney—hypertension	8.28e-05	0.00153	CbGeAlD
Erlotinib—CYP1A2—endocrine gland—hypertension	8.15e-05	0.00151	CbGeAlD
Erlotinib—CYP1A1—endocrine gland—hypertension	8.04e-05	0.00149	CbGeAlD
Erlotinib—Gefitinib—ALB—hypertension	7.87e-05	0.027	CrCbGaD
Erlotinib—CYP3A5—endocrine gland—hypertension	7.86e-05	0.00146	CbGeAlD
Erlotinib—CYP1A1—central nervous system—hypertension	7.25e-05	0.00134	CbGeAlD
Erlotinib—ABCB1—nephron tubule—hypertension	6.78e-05	0.00126	CbGeAlD
Erlotinib—ABCB1—adrenal cortex—hypertension	6.67e-05	0.00124	CbGeAlD
Erlotinib—ABCB1—heart—hypertension	6.45e-05	0.0012	CbGeAlD
Erlotinib—ABCB1—decidua—hypertension	6.28e-05	0.00116	CbGeAlD
Erlotinib—ABCB1—cardiovascular system—hypertension	6.09e-05	0.00113	CbGeAlD
Erlotinib—ABCB1—kidney—hypertension	5.96e-05	0.0011	CbGeAlD
Erlotinib—CYP3A4—endocrine gland—hypertension	5.9e-05	0.00109	CbGeAlD
Erlotinib—CYP2D6—endocrine gland—hypertension	5.81e-05	0.00108	CbGeAlD
Erlotinib—ABCB1—cortex of kidney—hypertension	5.8e-05	0.00107	CbGeAlD
Erlotinib—CYP3A4—central nervous system—hypertension	5.32e-05	0.000985	CbGeAlD
Erlotinib—CYP2D6—central nervous system—hypertension	5.23e-05	0.000969	CbGeAlD
Erlotinib—ABCB1—medulla oblongata—hypertension	5.2e-05	0.000964	CbGeAlD
Erlotinib—ABCB1—adrenal gland—hypertension	4.82e-05	0.000892	CbGeAlD
Erlotinib—ABCB1—endocrine gland—hypertension	4.18e-05	0.000774	CbGeAlD
Erlotinib—ABCB1—central nervous system—hypertension	3.76e-05	0.000697	CbGeAlD
Erlotinib—Gastrointestinal pain—Irbesartan—hypertension	2.54e-05	0.000167	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	2.54e-05	0.000167	CcSEcCtD
Erlotinib—Abdominal pain—Captopril—hypertension	2.53e-05	0.000167	CcSEcCtD
Erlotinib—Body temperature increased—Captopril—hypertension	2.53e-05	0.000167	CcSEcCtD
Erlotinib—Headache—Carvedilol—hypertension	2.53e-05	0.000167	CcSEcCtD
Erlotinib—Rash—Doxazosin—hypertension	2.52e-05	0.000166	CcSEcCtD
Erlotinib—Fatigue—Losartan—hypertension	2.52e-05	0.000166	CcSEcCtD
Erlotinib—Dermatitis—Doxazosin—hypertension	2.52e-05	0.000166	CcSEcCtD
Erlotinib—Gastrointestinal pain—Hydrochlorothiazide—hypertension	2.52e-05	0.000166	CcSEcCtD
Erlotinib—Vomiting—Fosinopril—hypertension	2.51e-05	0.000165	CcSEcCtD
Erlotinib—Nausea—Propranolol—hypertension	2.5e-05	0.000165	CcSEcCtD
Erlotinib—Oedema—Ramipril—hypertension	2.5e-05	0.000165	CcSEcCtD
Erlotinib—Headache—Doxazosin—hypertension	2.5e-05	0.000165	CcSEcCtD
Erlotinib—Pain—Losartan—hypertension	2.5e-05	0.000165	CcSEcCtD
Erlotinib—Constipation—Losartan—hypertension	2.5e-05	0.000165	CcSEcCtD
Erlotinib—Syncope—Lisinopril—hypertension	2.5e-05	0.000164	CcSEcCtD
Erlotinib—Vomiting—Eplerenone—hypertension	2.49e-05	0.000164	CcSEcCtD
Erlotinib—Rash—Fosinopril—hypertension	2.49e-05	0.000164	CcSEcCtD
Erlotinib—Dermatitis—Fosinopril—hypertension	2.49e-05	0.000164	CcSEcCtD
Erlotinib—Vomiting—Nifedipine—hypertension	2.48e-05	0.000163	CcSEcCtD
Erlotinib—Gastrointestinal pain—Furosemide—hypertension	2.47e-05	0.000163	CcSEcCtD
Erlotinib—Rash—Eplerenone—hypertension	2.47e-05	0.000163	CcSEcCtD
Erlotinib—Headache—Fosinopril—hypertension	2.47e-05	0.000163	CcSEcCtD
Erlotinib—Dermatitis—Eplerenone—hypertension	2.47e-05	0.000163	CcSEcCtD
Erlotinib—Diarrhoea—Valsartan—hypertension	2.47e-05	0.000163	CcSEcCtD
Erlotinib—Asthenia—Clonidine—hypertension	2.47e-05	0.000163	CcSEcCtD
Erlotinib—Vomiting—Verapamil—hypertension	2.47e-05	0.000163	CcSEcCtD
Erlotinib—Shock—Ramipril—hypertension	2.46e-05	0.000162	CcSEcCtD
Erlotinib—Abdominal pain—Perindopril—hypertension	2.46e-05	0.000162	CcSEcCtD
Erlotinib—Body temperature increased—Perindopril—hypertension	2.46e-05	0.000162	CcSEcCtD
Erlotinib—Diarrhoea—Olmesartan—hypertension	2.46e-05	0.000162	CcSEcCtD
Erlotinib—Headache—Eplerenone—hypertension	2.46e-05	0.000162	CcSEcCtD
Erlotinib—Rash—Nifedipine—hypertension	2.46e-05	0.000162	CcSEcCtD
Erlotinib—Nervous system disorder—Ramipril—hypertension	2.46e-05	0.000162	CcSEcCtD
Erlotinib—Dermatitis—Nifedipine—hypertension	2.45e-05	0.000162	CcSEcCtD
Erlotinib—Abdominal pain—Irbesartan—hypertension	2.45e-05	0.000162	CcSEcCtD
Erlotinib—Body temperature increased—Irbesartan—hypertension	2.45e-05	0.000162	CcSEcCtD
Erlotinib—Thrombocytopenia—Ramipril—hypertension	2.45e-05	0.000162	CcSEcCtD
Erlotinib—Oedema—Timolol—hypertension	2.45e-05	0.000161	CcSEcCtD
Erlotinib—Loss of consciousness—Lisinopril—hypertension	2.45e-05	0.000161	CcSEcCtD
Erlotinib—Rash—Verapamil—hypertension	2.45e-05	0.000161	CcSEcCtD
Erlotinib—Dermatitis—Verapamil—hypertension	2.44e-05	0.000161	CcSEcCtD
Erlotinib—Headache—Nifedipine—hypertension	2.44e-05	0.000161	CcSEcCtD
Erlotinib—Pruritus—Clonidine—hypertension	2.43e-05	0.000161	CcSEcCtD
Erlotinib—Abdominal pain—Hydrochlorothiazide—hypertension	2.43e-05	0.00016	CcSEcCtD
Erlotinib—Body temperature increased—Hydrochlorothiazide—hypertension	2.43e-05	0.00016	CcSEcCtD
Erlotinib—Skin disorder—Ramipril—hypertension	2.43e-05	0.00016	CcSEcCtD
Erlotinib—Infection—Timolol—hypertension	2.43e-05	0.00016	CcSEcCtD
Erlotinib—Headache—Verapamil—hypertension	2.43e-05	0.00016	CcSEcCtD
Erlotinib—Cough—Lisinopril—hypertension	2.43e-05	0.00016	CcSEcCtD
Erlotinib—Nausea—Indapamide—hypertension	2.42e-05	0.00016	CcSEcCtD
Erlotinib—Nausea—Diltiazem—hypertension	2.42e-05	0.00016	CcSEcCtD
Erlotinib—Asthenia—Trandolapril—hypertension	2.41e-05	0.000159	CcSEcCtD
Erlotinib—Shock—Timolol—hypertension	2.41e-05	0.000159	CcSEcCtD
Erlotinib—Nervous system disorder—Timolol—hypertension	2.4e-05	0.000158	CcSEcCtD
Erlotinib—Nausea—Carvedilol—hypertension	2.4e-05	0.000158	CcSEcCtD
Erlotinib—Asthenia—Enalapril—hypertension	2.4e-05	0.000158	CcSEcCtD
Erlotinib—Body temperature increased—Furosemide—hypertension	2.39e-05	0.000158	CcSEcCtD
Erlotinib—Abdominal pain—Furosemide—hypertension	2.39e-05	0.000158	CcSEcCtD
Erlotinib—Gastrointestinal pain—Losartan—hypertension	2.39e-05	0.000157	CcSEcCtD
Erlotinib—Dizziness—Valsartan—hypertension	2.39e-05	0.000157	CcSEcCtD
Erlotinib—Anorexia—Ramipril—hypertension	2.39e-05	0.000157	CcSEcCtD
Erlotinib—Skin disorder—Timolol—hypertension	2.38e-05	0.000157	CcSEcCtD
Erlotinib—Dizziness—Olmesartan—hypertension	2.38e-05	0.000157	CcSEcCtD
Erlotinib—Pruritus—Trandolapril—hypertension	2.37e-05	0.000157	CcSEcCtD
Erlotinib—Nausea—Doxazosin—hypertension	2.37e-05	0.000156	CcSEcCtD
Erlotinib—Arthralgia—Lisinopril—hypertension	2.37e-05	0.000156	CcSEcCtD
Erlotinib—Chest pain—Lisinopril—hypertension	2.37e-05	0.000156	CcSEcCtD
Erlotinib—Myalgia—Lisinopril—hypertension	2.37e-05	0.000156	CcSEcCtD
Erlotinib—Body temperature increased—Betaxolol—hypertension	2.37e-05	0.000156	CcSEcCtD
Erlotinib—Asthenia—Telmisartan—hypertension	2.37e-05	0.000156	CcSEcCtD
Erlotinib—Pruritus—Enalapril—hypertension	2.37e-05	0.000156	CcSEcCtD
Erlotinib—Anxiety—Lisinopril—hypertension	2.36e-05	0.000156	CcSEcCtD
Erlotinib—Diarrhoea—Clonidine—hypertension	2.35e-05	0.000155	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.35e-05	0.000155	CcSEcCtD
Erlotinib—Nausea—Fosinopril—hypertension	2.34e-05	0.000155	CcSEcCtD
Erlotinib—Anorexia—Timolol—hypertension	2.33e-05	0.000154	CcSEcCtD
Erlotinib—Pruritus—Telmisartan—hypertension	2.33e-05	0.000154	CcSEcCtD
Erlotinib—Nausea—Eplerenone—hypertension	2.33e-05	0.000154	CcSEcCtD
Erlotinib—Nausea—Nifedipine—hypertension	2.31e-05	0.000153	CcSEcCtD
Erlotinib—Abdominal pain—Losartan—hypertension	2.31e-05	0.000152	CcSEcCtD
Erlotinib—Body temperature increased—Losartan—hypertension	2.31e-05	0.000152	CcSEcCtD
Erlotinib—Nausea—Verapamil—hypertension	2.3e-05	0.000152	CcSEcCtD
Erlotinib—Asthenia—Captopril—hypertension	2.3e-05	0.000152	CcSEcCtD
Erlotinib—Diarrhoea—Trandolapril—hypertension	2.3e-05	0.000151	CcSEcCtD
Erlotinib—Vomiting—Valsartan—hypertension	2.3e-05	0.000151	CcSEcCtD
Erlotinib—Diarrhoea—Enalapril—hypertension	2.29e-05	0.000151	CcSEcCtD
Erlotinib—Vomiting—Olmesartan—hypertension	2.28e-05	0.000151	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Ramipril—hypertension	2.28e-05	0.00015	CcSEcCtD
Erlotinib—Rash—Valsartan—hypertension	2.28e-05	0.00015	CcSEcCtD
Erlotinib—Dizziness—Clonidine—hypertension	2.28e-05	0.00015	CcSEcCtD
Erlotinib—Dermatitis—Valsartan—hypertension	2.27e-05	0.00015	CcSEcCtD
Erlotinib—Oedema—Lisinopril—hypertension	2.27e-05	0.00015	CcSEcCtD
Erlotinib—Pruritus—Captopril—hypertension	2.27e-05	0.00015	CcSEcCtD
Erlotinib—Rash—Olmesartan—hypertension	2.27e-05	0.000149	CcSEcCtD
Erlotinib—Insomnia—Ramipril—hypertension	2.26e-05	0.000149	CcSEcCtD
Erlotinib—Dermatitis—Olmesartan—hypertension	2.26e-05	0.000149	CcSEcCtD
Erlotinib—Headache—Valsartan—hypertension	2.26e-05	0.000149	CcSEcCtD
Erlotinib—Diarrhoea—Telmisartan—hypertension	2.26e-05	0.000149	CcSEcCtD
Erlotinib—Infection—Lisinopril—hypertension	2.26e-05	0.000149	CcSEcCtD
Erlotinib—Headache—Olmesartan—hypertension	2.25e-05	0.000148	CcSEcCtD
Erlotinib—Shock—Lisinopril—hypertension	2.23e-05	0.000147	CcSEcCtD
Erlotinib—Asthenia—Perindopril—hypertension	2.23e-05	0.000147	CcSEcCtD
Erlotinib—Dyspnoea—Ramipril—hypertension	2.23e-05	0.000147	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Timolol—hypertension	2.23e-05	0.000147	CcSEcCtD
Erlotinib—Asthenia—Irbesartan—hypertension	2.23e-05	0.000147	CcSEcCtD
Erlotinib—Thrombocytopenia—Lisinopril—hypertension	2.22e-05	0.000147	CcSEcCtD
Erlotinib—Dizziness—Trandolapril—hypertension	2.22e-05	0.000146	CcSEcCtD
Erlotinib—Insomnia—Timolol—hypertension	2.21e-05	0.000146	CcSEcCtD
Erlotinib—Dizziness—Enalapril—hypertension	2.21e-05	0.000146	CcSEcCtD
Erlotinib—Asthenia—Hydrochlorothiazide—hypertension	2.21e-05	0.000146	CcSEcCtD
Erlotinib—Skin disorder—Lisinopril—hypertension	2.21e-05	0.000145	CcSEcCtD
Erlotinib—Dyspepsia—Ramipril—hypertension	2.2e-05	0.000145	CcSEcCtD
Erlotinib—Pruritus—Perindopril—hypertension	2.2e-05	0.000145	CcSEcCtD
Erlotinib—Pruritus—Irbesartan—hypertension	2.2e-05	0.000145	CcSEcCtD
Erlotinib—Diarrhoea—Captopril—hypertension	2.19e-05	0.000145	CcSEcCtD
Erlotinib—Vomiting—Clonidine—hypertension	2.19e-05	0.000144	CcSEcCtD
Erlotinib—Dyspnoea—Timolol—hypertension	2.18e-05	0.000144	CcSEcCtD
Erlotinib—Dizziness—Telmisartan—hypertension	2.18e-05	0.000144	CcSEcCtD
Erlotinib—Pruritus—Hydrochlorothiazide—hypertension	2.18e-05	0.000144	CcSEcCtD
Erlotinib—Decreased appetite—Ramipril—hypertension	2.18e-05	0.000143	CcSEcCtD
Erlotinib—Asthenia—Furosemide—hypertension	2.17e-05	0.000143	CcSEcCtD
Erlotinib—Rash—Clonidine—hypertension	2.17e-05	0.000143	CcSEcCtD
Erlotinib—Dermatitis—Clonidine—hypertension	2.17e-05	0.000143	CcSEcCtD
Erlotinib—Anorexia—Lisinopril—hypertension	2.16e-05	0.000143	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Ramipril—hypertension	2.16e-05	0.000143	CcSEcCtD
Erlotinib—Fatigue—Ramipril—hypertension	2.16e-05	0.000142	CcSEcCtD
Erlotinib—Headache—Clonidine—hypertension	2.16e-05	0.000142	CcSEcCtD
Erlotinib—Dyspepsia—Timolol—hypertension	2.15e-05	0.000142	CcSEcCtD
Erlotinib—Asthenia—Betaxolol—hypertension	2.15e-05	0.000142	CcSEcCtD
Erlotinib—Nausea—Valsartan—hypertension	2.14e-05	0.000141	CcSEcCtD
Erlotinib—Pruritus—Furosemide—hypertension	2.14e-05	0.000141	CcSEcCtD
Erlotinib—Constipation—Ramipril—hypertension	2.14e-05	0.000141	CcSEcCtD
Erlotinib—Nausea—Olmesartan—hypertension	2.13e-05	0.000141	CcSEcCtD
Erlotinib—Vomiting—Trandolapril—hypertension	2.13e-05	0.000141	CcSEcCtD
Erlotinib—Diarrhoea—Perindopril—hypertension	2.13e-05	0.00014	CcSEcCtD
Erlotinib—Decreased appetite—Timolol—hypertension	2.13e-05	0.00014	CcSEcCtD
Erlotinib—Vomiting—Enalapril—hypertension	2.13e-05	0.00014	CcSEcCtD
Erlotinib—Diarrhoea—Irbesartan—hypertension	2.12e-05	0.00014	CcSEcCtD
Erlotinib—Dizziness—Captopril—hypertension	2.12e-05	0.00014	CcSEcCtD
Erlotinib—Pruritus—Betaxolol—hypertension	2.12e-05	0.00014	CcSEcCtD
Erlotinib—Rash—Trandolapril—hypertension	2.12e-05	0.00014	CcSEcCtD
Erlotinib—Dermatitis—Trandolapril—hypertension	2.11e-05	0.000139	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Timolol—hypertension	2.11e-05	0.000139	CcSEcCtD
Erlotinib—Fatigue—Timolol—hypertension	2.11e-05	0.000139	CcSEcCtD
Erlotinib—Rash—Enalapril—hypertension	2.11e-05	0.000139	CcSEcCtD
Erlotinib—Dermatitis—Enalapril—hypertension	2.11e-05	0.000139	CcSEcCtD
Erlotinib—Diarrhoea—Hydrochlorothiazide—hypertension	2.11e-05	0.000139	CcSEcCtD
Erlotinib—Headache—Trandolapril—hypertension	2.1e-05	0.000139	CcSEcCtD
Erlotinib—Vomiting—Telmisartan—hypertension	2.1e-05	0.000138	CcSEcCtD
Erlotinib—Asthenia—Losartan—hypertension	2.1e-05	0.000138	CcSEcCtD
Erlotinib—Headache—Enalapril—hypertension	2.09e-05	0.000138	CcSEcCtD
Erlotinib—Pain—Timolol—hypertension	2.09e-05	0.000138	CcSEcCtD
Erlotinib—Rash—Telmisartan—hypertension	2.08e-05	0.000137	CcSEcCtD
Erlotinib—Dermatitis—Telmisartan—hypertension	2.08e-05	0.000137	CcSEcCtD
Erlotinib—Diarrhoea—Furosemide—hypertension	2.07e-05	0.000137	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Lisinopril—hypertension	2.07e-05	0.000136	CcSEcCtD
Erlotinib—Pruritus—Losartan—hypertension	2.07e-05	0.000136	CcSEcCtD
Erlotinib—Headache—Telmisartan—hypertension	2.07e-05	0.000136	CcSEcCtD
Erlotinib—Dizziness—Perindopril—hypertension	2.06e-05	0.000136	CcSEcCtD
Erlotinib—Insomnia—Lisinopril—hypertension	2.05e-05	0.000135	CcSEcCtD
Erlotinib—Dizziness—Irbesartan—hypertension	2.05e-05	0.000135	CcSEcCtD
Erlotinib—Diarrhoea—Betaxolol—hypertension	2.05e-05	0.000135	CcSEcCtD
Erlotinib—Gastrointestinal pain—Ramipril—hypertension	2.05e-05	0.000135	CcSEcCtD
Erlotinib—Nausea—Clonidine—hypertension	2.04e-05	0.000135	CcSEcCtD
Erlotinib—Vomiting—Captopril—hypertension	2.04e-05	0.000134	CcSEcCtD
Erlotinib—Dizziness—Hydrochlorothiazide—hypertension	2.03e-05	0.000134	CcSEcCtD
Erlotinib—Dyspnoea—Lisinopril—hypertension	2.02e-05	0.000133	CcSEcCtD
Erlotinib—Rash—Captopril—hypertension	2.02e-05	0.000133	CcSEcCtD
Erlotinib—Dermatitis—Captopril—hypertension	2.02e-05	0.000133	CcSEcCtD
Erlotinib—Headache—Captopril—hypertension	2.01e-05	0.000132	CcSEcCtD
Erlotinib—Gastrointestinal pain—Timolol—hypertension	2e-05	0.000132	CcSEcCtD
Erlotinib—Dizziness—Furosemide—hypertension	2e-05	0.000132	CcSEcCtD
Erlotinib—Dyspepsia—Lisinopril—hypertension	2e-05	0.000132	CcSEcCtD
Erlotinib—Diarrhoea—Losartan—hypertension	2e-05	0.000132	CcSEcCtD
Erlotinib—Nausea—Trandolapril—hypertension	1.99e-05	0.000131	CcSEcCtD
Erlotinib—Nausea—Enalapril—hypertension	1.99e-05	0.000131	CcSEcCtD
Erlotinib—Dizziness—Betaxolol—hypertension	1.98e-05	0.000131	CcSEcCtD
Erlotinib—Vomiting—Perindopril—hypertension	1.98e-05	0.00013	CcSEcCtD
Erlotinib—Abdominal pain—Ramipril—hypertension	1.98e-05	0.00013	CcSEcCtD
Erlotinib—Body temperature increased—Ramipril—hypertension	1.98e-05	0.00013	CcSEcCtD
Erlotinib—Decreased appetite—Lisinopril—hypertension	1.97e-05	0.00013	CcSEcCtD
Erlotinib—Vomiting—Irbesartan—hypertension	1.97e-05	0.00013	CcSEcCtD
Erlotinib—Rash—Perindopril—hypertension	1.96e-05	0.000129	CcSEcCtD
Erlotinib—Dermatitis—Perindopril—hypertension	1.96e-05	0.000129	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Lisinopril—hypertension	1.96e-05	0.000129	CcSEcCtD
Erlotinib—Nausea—Telmisartan—hypertension	1.96e-05	0.000129	CcSEcCtD
Erlotinib—Fatigue—Lisinopril—hypertension	1.96e-05	0.000129	CcSEcCtD
Erlotinib—Vomiting—Hydrochlorothiazide—hypertension	1.96e-05	0.000129	CcSEcCtD
Erlotinib—Rash—Irbesartan—hypertension	1.96e-05	0.000129	CcSEcCtD
Erlotinib—Dermatitis—Irbesartan—hypertension	1.95e-05	0.000129	CcSEcCtD
Erlotinib—Headache—Perindopril—hypertension	1.95e-05	0.000129	CcSEcCtD
Erlotinib—Headache—Irbesartan—hypertension	1.94e-05	0.000128	CcSEcCtD
Erlotinib—Pain—Lisinopril—hypertension	1.94e-05	0.000128	CcSEcCtD
Erlotinib—Constipation—Lisinopril—hypertension	1.94e-05	0.000128	CcSEcCtD
Erlotinib—Rash—Hydrochlorothiazide—hypertension	1.94e-05	0.000128	CcSEcCtD
Erlotinib—Dermatitis—Hydrochlorothiazide—hypertension	1.94e-05	0.000128	CcSEcCtD
Erlotinib—Abdominal pain—Timolol—hypertension	1.93e-05	0.000128	CcSEcCtD
Erlotinib—Body temperature increased—Timolol—hypertension	1.93e-05	0.000128	CcSEcCtD
Erlotinib—Dizziness—Losartan—hypertension	1.93e-05	0.000127	CcSEcCtD
Erlotinib—Headache—Hydrochlorothiazide—hypertension	1.93e-05	0.000127	CcSEcCtD
Erlotinib—Vomiting—Furosemide—hypertension	1.92e-05	0.000127	CcSEcCtD
Erlotinib—Rash—Furosemide—hypertension	1.91e-05	0.000126	CcSEcCtD
Erlotinib—Dermatitis—Furosemide—hypertension	1.91e-05	0.000126	CcSEcCtD
Erlotinib—Vomiting—Betaxolol—hypertension	1.91e-05	0.000126	CcSEcCtD
Erlotinib—Nausea—Captopril—hypertension	1.9e-05	0.000126	CcSEcCtD
Erlotinib—Headache—Furosemide—hypertension	1.9e-05	0.000125	CcSEcCtD
Erlotinib—Rash—Betaxolol—hypertension	1.89e-05	0.000125	CcSEcCtD
Erlotinib—Dermatitis—Betaxolol—hypertension	1.89e-05	0.000124	CcSEcCtD
Erlotinib—Headache—Betaxolol—hypertension	1.88e-05	0.000124	CcSEcCtD
Erlotinib—Gastrointestinal pain—Lisinopril—hypertension	1.86e-05	0.000122	CcSEcCtD
Erlotinib—Vomiting—Losartan—hypertension	1.86e-05	0.000122	CcSEcCtD
Erlotinib—Nausea—Perindopril—hypertension	1.85e-05	0.000122	CcSEcCtD
Erlotinib—Nausea—Irbesartan—hypertension	1.84e-05	0.000121	CcSEcCtD
Erlotinib—Rash—Losartan—hypertension	1.84e-05	0.000121	CcSEcCtD
Erlotinib—Dermatitis—Losartan—hypertension	1.84e-05	0.000121	CcSEcCtD
Erlotinib—Headache—Losartan—hypertension	1.83e-05	0.000121	CcSEcCtD
Erlotinib—Nausea—Hydrochlorothiazide—hypertension	1.83e-05	0.000121	CcSEcCtD
Erlotinib—Nausea—Furosemide—hypertension	1.8e-05	0.000119	CcSEcCtD
Erlotinib—Asthenia—Ramipril—hypertension	1.8e-05	0.000118	CcSEcCtD
Erlotinib—Abdominal pain—Lisinopril—hypertension	1.8e-05	0.000118	CcSEcCtD
Erlotinib—Body temperature increased—Lisinopril—hypertension	1.8e-05	0.000118	CcSEcCtD
Erlotinib—Nausea—Betaxolol—hypertension	1.78e-05	0.000117	CcSEcCtD
Erlotinib—Pruritus—Ramipril—hypertension	1.77e-05	0.000117	CcSEcCtD
Erlotinib—Asthenia—Timolol—hypertension	1.76e-05	0.000116	CcSEcCtD
Erlotinib—Nausea—Losartan—hypertension	1.73e-05	0.000114	CcSEcCtD
Erlotinib—Pruritus—Timolol—hypertension	1.73e-05	0.000114	CcSEcCtD
Erlotinib—Diarrhoea—Ramipril—hypertension	1.71e-05	0.000113	CcSEcCtD
Erlotinib—Diarrhoea—Timolol—hypertension	1.67e-05	0.00011	CcSEcCtD
Erlotinib—Dizziness—Ramipril—hypertension	1.66e-05	0.000109	CcSEcCtD
Erlotinib—Asthenia—Lisinopril—hypertension	1.63e-05	0.000107	CcSEcCtD
Erlotinib—Dizziness—Timolol—hypertension	1.62e-05	0.000107	CcSEcCtD
Erlotinib—Pruritus—Lisinopril—hypertension	1.61e-05	0.000106	CcSEcCtD
Erlotinib—Vomiting—Ramipril—hypertension	1.59e-05	0.000105	CcSEcCtD
Erlotinib—Rash—Ramipril—hypertension	1.58e-05	0.000104	CcSEcCtD
Erlotinib—Dermatitis—Ramipril—hypertension	1.58e-05	0.000104	CcSEcCtD
Erlotinib—Headache—Ramipril—hypertension	1.57e-05	0.000103	CcSEcCtD
Erlotinib—Vomiting—Timolol—hypertension	1.56e-05	0.000103	CcSEcCtD
Erlotinib—Diarrhoea—Lisinopril—hypertension	1.55e-05	0.000102	CcSEcCtD
Erlotinib—Rash—Timolol—hypertension	1.54e-05	0.000102	CcSEcCtD
Erlotinib—Dermatitis—Timolol—hypertension	1.54e-05	0.000102	CcSEcCtD
Erlotinib—Headache—Timolol—hypertension	1.53e-05	0.000101	CcSEcCtD
Erlotinib—Dizziness—Lisinopril—hypertension	1.5e-05	9.9e-05	CcSEcCtD
Erlotinib—Nausea—Ramipril—hypertension	1.49e-05	9.8e-05	CcSEcCtD
Erlotinib—Nausea—Timolol—hypertension	1.45e-05	9.58e-05	CcSEcCtD
Erlotinib—Vomiting—Lisinopril—hypertension	1.44e-05	9.52e-05	CcSEcCtD
Erlotinib—Rash—Lisinopril—hypertension	1.43e-05	9.44e-05	CcSEcCtD
Erlotinib—Dermatitis—Lisinopril—hypertension	1.43e-05	9.43e-05	CcSEcCtD
Erlotinib—Headache—Lisinopril—hypertension	1.42e-05	9.38e-05	CcSEcCtD
Erlotinib—Nausea—Lisinopril—hypertension	1.35e-05	8.89e-05	CcSEcCtD
Erlotinib—ABCB1—Metabolism—GNAS—hypertension	8.79e-07	8.58e-06	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—hypertension	8.73e-07	8.53e-06	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TP53—hypertension	8.67e-07	8.47e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—FGF2—hypertension	8.67e-07	8.47e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CALM1—hypertension	8.65e-07	8.45e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RHOA—hypertension	8.64e-07	8.44e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—COMT—hypertension	8.62e-07	8.43e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOE—hypertension	8.62e-07	8.42e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOB—hypertension	8.6e-07	8.41e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TH—hypertension	8.59e-07	8.39e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CALM2—hypertension	8.56e-07	8.37e-06	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—EP300—hypertension	8.55e-07	8.36e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—hypertension	8.55e-07	8.35e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PIK3R1—hypertension	8.55e-07	8.35e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAV1—hypertension	8.54e-07	8.35e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOA1—hypertension	8.52e-07	8.33e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALDH2—hypertension	8.51e-07	8.32e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GNB3—hypertension	8.5e-07	8.31e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARGC1A—hypertension	8.5e-07	8.31e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—hypertension	8.49e-07	8.3e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HMOX1—hypertension	8.46e-07	8.27e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	8.46e-07	8.26e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—hypertension	8.44e-07	8.25e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTM1—hypertension	8.37e-07	8.18e-06	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTEN—hypertension	8.37e-07	8.17e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GCG—hypertension	8.36e-07	8.17e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC2A4—hypertension	8.36e-07	8.17e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAT—hypertension	8.35e-07	8.16e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARA—hypertension	8.33e-07	8.14e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HBA1—hypertension	8.29e-07	8.1e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARA—hypertension	8.28e-07	8.09e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GNAS—hypertension	8.28e-07	8.09e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP11A1—hypertension	8.24e-07	8.05e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LPL—hypertension	8.21e-07	8.03e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOB—hypertension	8.11e-07	7.92e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTT1—hypertension	8.1e-07	7.91e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC9A1—hypertension	8.1e-07	7.91e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT1—hypertension	8.09e-07	7.91e-06	CbGpPWpGaD
Erlotinib—EGFR—Disease—MYC—hypertension	8.09e-07	7.9e-06	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—hypertension	8.07e-07	7.89e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AGT—hypertension	8.07e-07	7.88e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RELA—hypertension	8.04e-07	7.86e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADCY5—hypertension	8.04e-07	7.86e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AGT—hypertension	8.02e-07	7.84e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GPX1—hypertension	8.01e-07	7.83e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GCLC—hypertension	8e-07	7.82e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CETP—hypertension	8e-07	7.82e-06	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—EP300—hypertension	7.98e-07	7.8e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARG—hypertension	7.95e-07	7.77e-06	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—hypertension	7.94e-07	7.75e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP1A1—hypertension	7.93e-07	7.75e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PRKCA—hypertension	7.93e-07	7.75e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CALM1—hypertension	7.93e-07	7.75e-06	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TP53—hypertension	7.9e-07	7.72e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOE—hypertension	7.9e-07	7.72e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MTOR—hypertension	7.89e-07	7.71e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CALM1—hypertension	7.89e-07	7.71e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTM1—hypertension	7.89e-07	7.71e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOE—hypertension	7.86e-07	7.68e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—STK11—hypertension	7.86e-07	7.68e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP19A1—hypertension	7.86e-07	7.68e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—hypertension	7.84e-07	7.66e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAV1—hypertension	7.83e-07	7.65e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOA1—hypertension	7.81e-07	7.63e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CD36—hypertension	7.81e-07	7.63e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—INS—hypertension	7.8e-07	7.62e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAV1—hypertension	7.79e-07	7.61e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOA1—hypertension	7.77e-07	7.59e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LPL—hypertension	7.74e-07	7.56e-06	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—hypertension	7.71e-07	7.53e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP17A1—hypertension	7.66e-07	7.49e-06	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTEN—hypertension	7.61e-07	7.44e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ENO1—hypertension	7.59e-07	7.41e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS1—hypertension	7.59e-07	7.41e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—hypertension	7.58e-07	7.41e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADCY5—hypertension	7.58e-07	7.41e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GPX1—hypertension	7.55e-07	7.38e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARG—hypertension	7.51e-07	7.34e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PRKCA—hypertension	7.48e-07	7.31e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP1A1—hypertension	7.48e-07	7.31e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—hypertension	7.41e-07	7.24e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—hypertension	7.4e-07	7.23e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	7.38e-07	7.21e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—INS—hypertension	7.37e-07	7.2e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CD36—hypertension	7.36e-07	7.19e-06	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AKT1—hypertension	7.32e-07	7.15e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—COMT—hypertension	7.3e-07	7.14e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CTGF—hypertension	7.3e-07	7.14e-06	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—EP300—hypertension	7.26e-07	7.09e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARA—hypertension	7.26e-07	7.09e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT2—hypertension	7.24e-07	7.07e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HMGCR—hypertension	7.24e-07	7.07e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—hypertension	7.21e-07	7.04e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GNB3—hypertension	7.2e-07	7.04e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARGC1A—hypertension	7.2e-07	7.04e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HMOX1—hypertension	7.17e-07	7.01e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—hypertension	7.15e-07	6.98e-06	CbGpPWpGaD
Erlotinib—ABL1—Immune System—AKT1—hypertension	7.11e-07	6.95e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADRA2A—hypertension	7.08e-07	6.92e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAT—hypertension	7.07e-07	6.91e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	7.03e-07	6.87e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AGT—hypertension	7.03e-07	6.87e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GNAS—hypertension	7.01e-07	6.85e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—hypertension	6.97e-07	6.81e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CALM1—hypertension	6.91e-07	6.75e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOE—hypertension	6.89e-07	6.73e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARG—hypertension	6.88e-07	6.73e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOB—hypertension	6.87e-07	6.71e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—hypertension	6.86e-07	6.7e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARG—hypertension	6.85e-07	6.69e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARA—hypertension	6.84e-07	6.68e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3R1—hypertension	6.84e-07	6.68e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—hypertension	6.84e-07	6.68e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CDKN1A—hypertension	6.83e-07	6.68e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAV1—hypertension	6.82e-07	6.67e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PTEN—hypertension	6.82e-07	6.66e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOA1—hypertension	6.81e-07	6.65e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—hypertension	6.79e-07	6.63e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—INS—hypertension	6.75e-07	6.6e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—hypertension	6.75e-07	6.6e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—hypertension	6.75e-07	6.6e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—INS—hypertension	6.71e-07	6.56e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTM1—hypertension	6.68e-07	6.53e-06	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—AKT1—hypertension	6.68e-07	6.52e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MAPK8—hypertension	6.67e-07	6.52e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AKT1—hypertension	6.65e-07	6.5e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TH—hypertension	6.63e-07	6.48e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AGT—hypertension	6.62e-07	6.47e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CALM2—hypertension	6.61e-07	6.46e-06	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—hypertension	6.59e-07	6.44e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LPL—hypertension	6.56e-07	6.41e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CALM1—hypertension	6.51e-07	6.36e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—EP300—hypertension	6.5e-07	6.35e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOE—hypertension	6.49e-07	6.34e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3R1—hypertension	6.46e-07	6.31e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—hypertension	6.46e-07	6.31e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC2A4—hypertension	6.45e-07	6.3e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GCG—hypertension	6.45e-07	6.3e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAV1—hypertension	6.43e-07	6.28e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADCY5—hypertension	6.42e-07	6.27e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOA1—hypertension	6.41e-07	6.27e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GPX1—hypertension	6.4e-07	6.25e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PRKCA—hypertension	6.33e-07	6.19e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP1A1—hypertension	6.33e-07	6.19e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SRC—hypertension	6.32e-07	6.18e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—hypertension	6.25e-07	6.11e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT1—hypertension	6.25e-07	6.1e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CD36—hypertension	6.23e-07	6.09e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—hypertension	6.19e-07	6.05e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VEGFA—hypertension	6.16e-07	6.02e-06	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—hypertension	6.08e-07	5.94e-06	CbGpPWpGaD
Erlotinib—EGFR—Immune System—AKT1—hypertension	6.08e-07	5.94e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—STK11—hypertension	6.06e-07	5.93e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP19A1—hypertension	6.06e-07	5.93e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARG—hypertension	6e-07	5.86e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—hypertension	5.92e-07	5.79e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3R1—hypertension	5.92e-07	5.79e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—hypertension	5.92e-07	5.78e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—hypertension	5.91e-07	5.77e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—hypertension	5.9e-07	5.77e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3R1—hypertension	5.89e-07	5.75e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—hypertension	5.89e-07	5.75e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—INS—hypertension	5.88e-07	5.75e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARA—hypertension	5.79e-07	5.66e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MYC—hypertension	5.66e-07	5.54e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARG—hypertension	5.65e-07	5.52e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—hypertension	5.65e-07	5.52e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—COMT—hypertension	5.64e-07	5.51e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AGT—hypertension	5.61e-07	5.48e-06	CbGpPWpGaD
Erlotinib—EGFR—Disease—AKT1—hypertension	5.61e-07	5.48e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—hypertension	5.57e-07	5.45e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GNB3—hypertension	5.56e-07	5.43e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARGC1A—hypertension	5.56e-07	5.43e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—INS—hypertension	5.54e-07	5.42e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HMOX1—hypertension	5.53e-07	5.41e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CALM1—hypertension	5.52e-07	5.39e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOE—hypertension	5.5e-07	5.37e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAT—hypertension	5.46e-07	5.34e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTEN—hypertension	5.45e-07	5.33e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAV1—hypertension	5.45e-07	5.32e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOA1—hypertension	5.43e-07	5.31e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—hypertension	5.42e-07	5.29e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GNAS—hypertension	5.41e-07	5.29e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—hypertension	5.39e-07	5.27e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—hypertension	5.38e-07	5.26e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOB—hypertension	5.3e-07	5.18e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—EP300—hypertension	5.2e-07	5.08e-06	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—AKT1—hypertension	5.17e-07	5.05e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—hypertension	5.16e-07	5.04e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3R1—hypertension	5.16e-07	5.04e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTM1—hypertension	5.16e-07	5.04e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTEN—hypertension	5.15e-07	5.03e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—hypertension	5.08e-07	4.97e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LPL—hypertension	5.06e-07	4.95e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADCY5—hypertension	4.95e-07	4.84e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GPX1—hypertension	4.94e-07	4.83e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—EP300—hypertension	4.91e-07	4.8e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PRKCA—hypertension	4.89e-07	4.78e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP1A1—hypertension	4.89e-07	4.78e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3R1—hypertension	4.86e-07	4.75e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—hypertension	4.86e-07	4.75e-06	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—AKT1—hypertension	4.82e-07	4.71e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CD36—hypertension	4.81e-07	4.7e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARG—hypertension	4.79e-07	4.68e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTEN—hypertension	4.72e-07	4.62e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—hypertension	4.72e-07	4.61e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—hypertension	4.72e-07	4.61e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTEN—hypertension	4.7e-07	4.59e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—INS—hypertension	4.7e-07	4.59e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TP53—hypertension	4.65e-07	4.55e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—hypertension	4.56e-07	4.45e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—EP300—hypertension	4.5e-07	4.4e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—EP300—hypertension	4.48e-07	4.38e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARA—hypertension	4.47e-07	4.37e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—hypertension	4.45e-07	4.34e-06	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—AKT1—hypertension	4.39e-07	4.29e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AGT—hypertension	4.33e-07	4.23e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—hypertension	4.31e-07	4.21e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—hypertension	4.26e-07	4.16e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CALM1—hypertension	4.26e-07	4.16e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOE—hypertension	4.24e-07	4.15e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAV1—hypertension	4.2e-07	4.11e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOA1—hypertension	4.19e-07	4.1e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3R1—hypertension	4.12e-07	4.02e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—hypertension	4.12e-07	4.02e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTEN—hypertension	4.11e-07	4.02e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AKT1—hypertension	3.93e-07	3.84e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—EP300—hypertension	3.92e-07	3.83e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTEN—hypertension	3.88e-07	3.79e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—hypertension	3.77e-07	3.68e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—EP300—hypertension	3.7e-07	3.61e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARG—hypertension	3.7e-07	3.61e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—hypertension	3.64e-07	3.56e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—INS—hypertension	3.62e-07	3.54e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—hypertension	3.32e-07	3.25e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTEN—hypertension	3.28e-07	3.21e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3R1—hypertension	3.18e-07	3.11e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—hypertension	3.18e-07	3.11e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AKT1—hypertension	3.14e-07	3.07e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—EP300—hypertension	3.13e-07	3.06e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AKT1—hypertension	2.97e-07	2.9e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—hypertension	2.91e-07	2.84e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AKT1—hypertension	2.72e-07	2.66e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AKT1—hypertension	2.71e-07	2.64e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTEN—hypertension	2.54e-07	2.48e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—EP300—hypertension	2.42e-07	2.36e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AKT1—hypertension	2.37e-07	2.32e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AKT1—hypertension	2.23e-07	2.18e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AKT1—hypertension	1.89e-07	1.85e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AKT1—hypertension	1.46e-07	1.43e-06	CbGpPWpGaD
